MedPath

determination for the effect of reducing the daily variation of intraocular pressure for glaucoma patients, before and after the addition of Ripasudil 0.4% eye drops using the trigger fish system

Not Applicable
Recruiting
Conditions
glaucoma
Registration Number
JPRN-UMIN000041093
Lead Sponsor
Yokohama City University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients already on Ripasudil 0.4% eye drops 2) Patients who cannot wear contact lenses (patients with contraindicated target diseases as listed in the Triggerfish package insert) 3) Patients who cannot continue to use Ripasudil 0.4% due to hypersensitivity or other problems to eye drops 4) Other patients who are deemed unsuitable for inclusion in the subject by the physician's judgment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath